NYSE · Diagnostics & Research · USD
Mettler-Toledo International Inc. (MTD) Stock Analysis
Mettler-Toledo International Inc. (MTD) is a Diagnostics & Research stock listed on NYSE and quoted in US Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
MTD Key Statistics
As of Oct 21, 2026Trading
- Open
- $1,606.00
- Previous Close
- $1,634.01
- Day's Range
- 1,606.00–1,681.26
- 52-Week Range
- 1,023.05–1,681.26
- Volume
- 140.30K
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 1.19
Valuation
- Market Cap
- $33.62B
- P/E Ratio
- 37.82
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 32.42
- PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
- 3.03
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 8.13
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 44.37
Financials (FY)
- Revenue (FY)
- $4.03B+3.98%
- Net Income (FY)
- $869.19M+0.70%
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 21.91%
- Shares Outstanding
- 20.04M
- 1-Year Return
- +21.10%
Dividend and dates
- Earnings Date
- November 5, 2026
- Avg Volume
- 197.20K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 21, 2026, MTD closed at $1,677.94, +21.10% over 1 year.
Mettler-Toledo International Inc. (MTD) has a market capitalization of $33.62B.
In fiscal 2025, MTD reported revenue of $4.03B.
MTD Stock Return by Calendar Year
Mettler-Toledo International Inc. (MTD) 10-year return: what $10,000 became
- 1 year
- $10,000 $12,110
- +21.10%
- 5 years
- $10,000 $11,677
- +16.77%
- 10 years
- $10,000 $41,204
- +312.04%
If you had invested $10,000 in Mettler-Toledo International Inc. (MTD) 10 years ago, at the close on October 21, 2016, it would have been worth $41,204 at the close on October 21, 2026: +312.04% in total, +15.21% a year. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | +20.35% |
| 2025 | +13.93% |
| 2024 | +0.88% |
| 2023 | −16.08% |
| 2022 | −14.83% |
| 2021 | +48.92% |
| 2020 | +43.67% |
| 2019 | +40.26% |
| 2018 | −8.71% |
| 2017 | +48.01% |
| 2016 (partial year) | +5.05% |
As of October 21, 2026.
MTD Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $4.03B | $869.19M | 21.6% |
| 2024 | $3.87B | $863.14M | 22.3% |
| 2023 | $3.79B | $788.78M | 20.8% |
| 2022 | $3.92B | $872.50M | 22.3% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $4.03B | $2.39B | $1.12B | $869.19M | 21.6% |
| 2024 | $3.87B | $2.33B | $1.13B | $863.14M | 22.3% |
| 2023 | $3.79B | $2.24B | $1.08B | $788.78M | 20.8% |
| 2022 | $3.92B | $2.31B | $1.13B | $872.50M | 22.3% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
MTD Valuation vs Diagnostics & Research Median
Median of 45 stocks| Metric | MTD | Diagnostics & Research median | vs median |
|---|---|---|---|
| P/E | 37.82 | 37.59 | 1% above |
| P/S ratio | 8.13 | 5.23 | 56% above |
| Profit margin | 21.91% | −0.93% | 22.8 pts above |
Medians across 45 Diagnostics & Research stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.
Recent News
Morgan Stanley Maintains Equal-Weight on Mettler-Toledo Intl, Raises Price Target to $1575
BenzingaMettler-Toledo International Inc. to Host Investor Meeting
YahooMettler-Toledo (MTD) Upgraded to Buy: What Does It Mean for the Stock?
YahooMettler-Toledo International Inc. to Host Third Quarter 2026 Earnings Conference Call
YahooMettler-Toledo (MTD): AI-Driven Pharma R&D Productivity Catalyzes Growth
YahooShares Of Mettler-Toledo International Are Still Too Pricey For My Liking
SeekingAlpha
All 20 articles ↓Show fewer ↑
Barclays Maintains Overweight on Mettler-Toledo Intl, Raises Price Target to $1700
BenzingaMettler-Toledo International: Why The Valuation Is Problematic
SeekingAlphaMettler Toledo International (MTD), Why Is It Getting Fresh Attention?
YahooHere's How Much $100 Invested In Mettler-Toledo Intl 20 Years Ago Would Be Worth Today
BenzingaWhat Makes Mettler-Toledo International (MTD) an Attractive Bet?
YahooIs Mettler-Toledo Stock Underperforming the Nasdaq?
BarchartResearch Tools & Consumables Stocks Q2 Teardown: Mettler-Toledo (NYSE:MTD) Vs The Rest
YahooMettler-Toledo International (NYSE:MTD): A Quality Stock for Long-Term Compounding
ChartMillRothschild & Co Initiates Coverage of Mettler-Toledo International (MTD) at Sell
FintelRedburn starts Mettler-Toledo at Sell, sees valuation outpacing growth
YahooRothschild & Co Initiates Coverage On Mettler-Toledo Intl with Sell Rating, Announces Price Target of $1200
BenzingaRBC Capital Initiates Coverage of Mettler-Toledo International (MTD) with Sector Perform Recommendation
FintelAt Mettler-Toledo Intl, Patrick Kaltenbach Chooses To Exercise Options, Resulting In $346K
BenzingaRBC Capital Initiates Coverage On Mettler-Toledo Intl with Sector Perform Rating, Announces Price Target of $1515
Benzinga
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Diagnostics & Research Stocks
Thermo Fisher Scientific Inc.
$256.61B
DHRDanaher Corporation
$164.40B
NTRANatera, Inc.
$59.59B
AAgilent Technologies, Inc.
$50.12B
IQVIQVIA Holdings Inc.
$45.53B
WATWaters Corporation
$44.92B
Popular Healthcare Stocks
Eli Lilly and Company
$1.13T
JNJJohnson & Johnson
$621.22B
ABBVAbbVie Inc.
$503.27B
UNHUnitedHealth Group Incorporated
$374.30B
MRKMerck & Co., Inc.
$369.78B

















